Pivmecillinam vs Nitrofurantoin for UTI
What You Need to Know Before You Apply
What is the purpose of this trial?
Multicenter, Randomized, Open-label, Active-controlled Study with Blinded Assessor to Evaluate the Safety and Tolerability of Pivmecillinam Hydrochloride versus Nitrofurantoin for the Treatment of Female Pediatric Subjects, 12 Years to Less Than 18 Years of Age, with Uncomplicated Urinary Tract Infections
Are You a Good Fit for This Trial?
This trial is for girls ages 12 to under 18 who have an uncomplicated urinary tract infection (UTI). Participants should be generally healthy aside from the UTI and not have complicated or chronic kidney problems.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares two antibiotics, pivmecillinam (Pivya) and nitrofurantoin, to see which works better and is safer for treating UTIs in adolescent girls. Patients are randomly assigned to one of the two treatments.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
185 mg (pivmecillinam HCl 200 mg, henceforth referred to as pivmecillinam 185 mg) TID for 5 days, taken orally with or without food
100 mg (nitrofurantoin monohydrate/macrocrystalline capsule) BID for 5 days, taken orally with food
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alembic Therapeutics
Lead Sponsor
FOTREA CRO
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.